Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer's Disease

被引:4
|
作者
Zhu, Yueli [1 ]
Guo, Xiaoming [2 ]
Zhu, Feng [1 ]
Zhang, Qin [1 ,3 ]
Yang, Yunmei [1 ,3 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Geriatr, Hangzhou 310003, Peoples R China
[2] Tongde Hosp Zhejiang Prov, Dept Neurosurg, Hangzhou 310012, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Key Lab Diag & Treatment Aging & Phys Chem Injury, Hangzhou 310003, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; growth-associated protein 43; Apolipoprotein E epsilon 4; synaptic loss; biomarker; AMYLOID-BETA; SYNAPSE LOSS; PROTEIN; TAU; NEUROGRANIN; GENOTYPE; CA1;
D O I
10.3390/cells12010013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The growth-associated protein 43 (GAP-43) is a presynaptic phosphoprotein in cerebrospinal fluid (CSF). The epsilon 4 allele of apolipoprotein E (APOE) is an important genetic risk factor for Alzheimer's disease (AD). We aimed to evaluate the association of CSF GAP-43 with cognition and whether this correlation was related to the APOE epsilon 4 status. We recruited participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, and they were divided into cognitively normal (CN) epsilon 4 negative (CN epsilon 4-), CN epsilon 4 positive (CN epsilon 4+), mild cognitive impairment (MCI) epsilon 4 negative (MCI epsilon 4-), MCI epsilon 4 positive (MCI epsilon 4+), AD epsilon 4 negative (AD epsilon 4-), and AD epsilon 4 positive (AD epsilon 4+) groups. Spearman's correlation was utilized to evaluate the relationship between CSF GAP-43 and core AD biomarkers at the baseline. We performed receiver-operating characteristic (ROC) curve analyses to investigate the diagnostic accuracy of CSF GAP-43. The correlations between CSF GAP-43 and the Mini-Mental State Examination (MMSE) scores and brain atrophy at baseline were assessed by using multiple linear regression, while the association between CSF GAP-43 and MMSE scores at the follow-up was tested by performing the generalized estimating equation (GEE). The role of CSF GAP-43 in the conversion from MCI to AD was evaluated using the Cox proportional hazard model. We found that the CSF GAP-43 level was significantly increased in MCI epsilon 4+, AD epsilon 4- and AD epsilon 4+ groups compared with CN epsilon 4- or MCI epsilon 4- group. The negative associations between the CSF GAP-43 and MMSE scores at the baseline and follow-up were found in MCI epsilon 4- and MCI epsilon 4+ groups. In addition, baseline CSF GAP-43 was able to predict the clinical progression from MCI to AD. CSF GAP-43 may be a promising biomarker to screen cognition for AD. The effects of CSF GAP-43 on cognition were suspected to be relevant to APOE epsilon 4 status.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer's Disease
    Fan, Yulan
    Gao, Ying
    Therriault, Joseph
    Luo, Jing
    Ba, Maowen
    Zhang, Hua
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [2] CSF cortisol in Alzheimer's disease and mild cognitive impairment
    Popp, Julius
    Schaper, Karsten
    Koelsch, Heike
    Cvetanovska, Gabriela
    Rommel, Fatima
    Klingmueller, Dietrich
    Dodel, Richard
    Wuellner, Ullrich
    Jessen, Frank
    [J]. NEUROBIOLOGY OF AGING, 2009, 30 (03) : 498 - 500
  • [3] Association Between the APOE ε2/ε4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans
    Ren, Dianxu
    Lopez, Oscar L.
    Lingler, Jennifer H.
    Conley, Yvette
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2021, 81 (03) : 943 - 948
  • [4] Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment
    Hu, William T.
    Chen-Plotkin, Alice
    Arnold, Steven E.
    Grossman, Murray
    Clark, Christopher M.
    Shaw, Leslie M.
    Pickering, Eve
    Kuhn, Max
    Chen, Yu
    McCluskey, Leo
    Elman, Lauren
    Karlawish, Jason
    Hurtig, Howard I.
    Siderowf, Andrew
    Lee, Virginia M. -Y.
    Soares, Holly
    Trojanowski, John Q.
    [J]. ACTA NEUROPATHOLOGICA, 2010, 119 (06) : 669 - 678
  • [5] Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease
    Oviedo, Diana C.
    Lezcano, Hector
    Perez, Ambar R.
    Villarreal, Alcibiades E.
    Carreira, Maria B.
    Isaza, Baltasar
    Wesley, Lavinia
    Grajales, Shantal A.
    Fernandez, Sara
    Frank, Ana
    Britton, Gabrielle B.
    [J]. AIMS NEUROSCIENCE, 2018, 5 (02) : 148 - 161
  • [6] CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
    Andreasen, N
    Blennow, K
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2005, 107 (03) : 165 - 173
  • [7] Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
    William T. Hu
    Alice Chen-Plotkin
    Steven E. Arnold
    Murray Grossman
    Christopher M. Clark
    Leslie M. Shaw
    Eve Pickering
    Max Kuhn
    Yu Chen
    Leo McCluskey
    Lauren Elman
    Jason Karlawish
    Howard I. Hurtig
    Andrew Siderowf
    Virginia M.-Y. Lee
    Holly Soares
    John Q. Trojanowski
    [J]. Acta Neuropathologica, 2010, 119 : 669 - 678
  • [8] Biomarkers of Alzheimer's disease in the CSF of patients with mild cognitive impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Rodriguez-Borja, E.
    Ruiz-Vegara, M.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S166 - S166
  • [9] Spatial cognition impairment in Alzheimer's disease, vascular dementia and mild cognitive impairment
    Laczo, J.
    Hort, J.
    Vlcek, K.
    Bojar, M.
    Bures, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 85 - 86
  • [10] Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia
    Park, Jong-Il
    [J]. PSYCHOGERIATRICS, 2024, 24 (03) : 555 - 564